Documentos relacionados

1. Striking Neurochemical and Behavioral Differences in the Mode of Action of Selegiline and Rasagiline.
2. Comparative effectiveness of dopamine agonists and monoamine oxidase type-B inhibitors for Parkinson's disease: a multiple treatment comparison meta-analysis.
3. [Parkinson's disease: pathogenesis, aetiology, symptoms, diagnostics, and its course].
4. Effects of monotherapy with a monoamine oxidase B inhibitor on motor symptoms in Parkinson's disease are dependent on frontal function.
5. A critical appraisal of MAO-B inhibitors in the treatment of Parkinson's disease.
6. A multiple treatment comparison meta-analysis of monoamine oxidase type B inhibitors for Parkinson's disease.
7. [Dementia in morbus Parkinson: reasonable diagnostics and rational therapy].
8. Monoamine-oxidase Type B Inhibitors and Cognitive Functions in Parkinson's Disease: Beyond the Primary Mechanism of Action.
9. Comparative efficacy and safety of monoamine oxidase type B inhibitors plus channel blockers and monoamine oxidase type B inhibitors as adjuvant therapy to levodopa in the treatment of Parkinson's disease: a network meta-analysis of randomized controlled trials.
10. [Parkinson's disease: current standards in diagnostics and therapy].